A recent court ruling allows thousands of lawsuits alleging social media addiction to proceed against tech giants like Meta. Separately, researchers are exploring the potential of GLP-1 drugs, such as Ozempic, to treat brain conditions like Alzheimer's disease and dementia, drawing parallels to their impact on obesity and diabetes. AI
RANK_REASON The cluster discusses a court ruling on lawsuits against tech giants and potential medical applications of existing drugs, which falls under commentary and other news rather than a specific AI-related event.
Read on Mastodon — mastodon.social →
- Mastodon
- Meta
- Alzheimer's disease
- dementia
- diabetes
- Eli Lilly and Company
- GLP-1
- Novo Nordisk
- obesity
- Ozempic
- semaglutide
- tirzepatide
AI-generated summary · Google Gemini · from 2 sources. How we write summaries →